buprenorphine LA
Marketedupdated 2mo agoby $INDV Indivior Pharmaceuticals, Inc.
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 23 investigational indications.
all catalysts(25)
approval · 25
Nov 30, 2017
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Mar 5, 2018
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Oct 7, 2019
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Feb 4, 2020
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Jun 15, 2020
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Mar 4, 2021
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
May 11, 2021
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Jun 17, 2021
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Sep 22, 2021
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Jun 17, 2022
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Aug 23, 2022
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Jan 6, 2023
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Mar 13, 2023
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
May 23, 2023
approval
BRIXADI (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Jul 3, 2023
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Sep 12, 2023
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Dec 15, 2023
approval
BRIXADI (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Dec 15, 2023
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Apr 19, 2024
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Feb 21, 2025
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Mar 28, 2025
approval
BRIXADI (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Apr 11, 2025
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Aug 29, 2025
approval
BRIXADI (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Dec 22, 2025
approval
SUBLOCADE (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
Dec 22, 2025
approval
BRIXADI (BUPRENORPHINE) — FDA approval
buprenorphine LA
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that